DistantNews
Support us
Thai police intercept pickup with 506,000 'kuda' pills bound for Malaysia
๐Ÿ‡ฒ๐Ÿ‡พ Malaysia /Crime & Justice

Thai police intercept pickup with 506,000 'kuda' pills bound for Malaysia

From Utusan Malaysia · () Malay

Translated from Malay, summarized and contextualized by DistantNews.

At a glance

News Named sources Outcome reported
  • Pattani police intercepted a pickup truck carrying 506,000 methamphetamine pills, known as 'kuda' pills, near the Koh Mo Kaeng checkpoint in Narathiwat.
  • The operation led to the arrest of a man believed to be part of a major drug syndicate smuggling narcotics in southern Thailand.
  • The suspect admitted to making three previous trips, earning RM24,272 per delivery, with the pills destined for Malaysia.

Pattani police in Thailand intercepted a pickup truck carrying a significant haul of 506,000 methamphetamine pills, commonly referred to as 'kuda' pills, near the Koh Mo Kaeng checkpoint in Narathiwat province. The operation occurred around 9 p.m. on Tuesday.

The Anti-Narcotics Division of Pattani Provincial Police arrested a man in his 30s, who is suspected of being a member of a major drug syndicate actively involved in smuggling narcotics in the southern region of Thailand. The suspect was reportedly transporting the pills from central Thailand towards Narathiwat province in a white pickup truck.

During initial questioning, the suspect revealed the location where the drugs were hidden. Authorities discovered the 506,000 'kuda' pills concealed within a modified secret compartment in the rear cabin of the pickup. The suspect confessed that this was his third trip transporting drugs from central Thailand to Narathiwat, receiving RM24,272 for each delivery. The pills were intended for distribution to specific individuals in Narathiwat before being smuggled into Malaysia via Kelantan.

DistantNews Editorial

Originally published by Utusan Malaysia in Malay. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.